The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-Invasive Neuromodulatory Devices Market Research Report 2024
Synopsis
Non-Invasive Neuromodulation is neuromodulation that does not require a surgical procedure, such as TMS, TENS, ECT, or tES.
Global Non-Invasive Neuromodulatory Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Invasive Neuromodulatory Devices market research.
Key manufacturers engaged in the Non-Invasive Neuromodulatory Devices industry include Neuroelectrics, Aneuvo, Soterix Medical, Magstim, BrainsWay, ElectroCore Medical, NeuroCare Group, Koninklijke Philips and NESA World, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Non-Invasive Neuromodulatory Devices were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Invasive Neuromodulatory Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Invasive Neuromodulatory Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Neuroelectrics
Aneuvo
Soterix Medical
Magstim
BrainsWay
ElectroCore Medical
NeuroCare Group
Koninklijke Philips
NESA World
DEYMED Diagnostic
electroCore
Medistar
Vagustim
Segment by Type
Transcutaneous Supraorbital Neurostimulation
Single-Pulse Transcranial Magnetic Stimulation
Non-invasive Vagal Nerve Stimulation
Others
Segment by Application
Hospitals & Clinics
Cognitive Care Centers
Research Institutes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-Invasive Neuromodulatory Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Non-Invasive Neuromodulation is neuromodulation that does not require a surgical procedure, such as TMS, TENS, ECT, or tES.
Global Non-Invasive Neuromodulatory Devices market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Invasive Neuromodulatory Devices market research.
Key manufacturers engaged in the Non-Invasive Neuromodulatory Devices industry include Neuroelectrics, Aneuvo, Soterix Medical, Magstim, BrainsWay, ElectroCore Medical, NeuroCare Group, Koninklijke Philips and NESA World, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Non-Invasive Neuromodulatory Devices were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Invasive Neuromodulatory Devices market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Invasive Neuromodulatory Devices market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Neuroelectrics
Aneuvo
Soterix Medical
Magstim
BrainsWay
ElectroCore Medical
NeuroCare Group
Koninklijke Philips
NESA World
DEYMED Diagnostic
electroCore
Medistar
Vagustim
Segment by Type
Transcutaneous Supraorbital Neurostimulation
Single-Pulse Transcranial Magnetic Stimulation
Non-invasive Vagal Nerve Stimulation
Others
Segment by Application
Hospitals & Clinics
Cognitive Care Centers
Research Institutes
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-Invasive Neuromodulatory Devices report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Non-Invasive Neuromodulatory Devices Market Overview
1.1 Product Overview and Scope of Non-Invasive Neuromodulatory Devices
1.2 Non-Invasive Neuromodulatory Devices Segment by Type
1.2.1 Global Non-Invasive Neuromodulatory Devices Market Value Comparison by Type (2023-2029)
1.2.2 Transcutaneous Supraorbital Neurostimulation
1.2.3 Single-Pulse Transcranial Magnetic Stimulation
1.2.4 Non-invasive Vagal Nerve Stimulation
1.2.5 Others
1.3 Non-Invasive Neuromodulatory Devices Segment by Application
1.3.1 Global Non-Invasive Neuromodulatory Devices Market Value by Application: (2023-2029)
1.3.2 Hospitals & Clinics
1.3.3 Cognitive Care Centers
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Non-Invasive Neuromodulatory Devices Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Neuromodulatory Devices Revenue 2018-2029
1.4.2 Global Non-Invasive Neuromodulatory Devices Sales 2018-2029
1.4.3 Global Non-Invasive Neuromodulatory Devices Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-Invasive Neuromodulatory Devices Market Competition by Manufacturers
2.1 Global Non-Invasive Neuromodulatory Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-Invasive Neuromodulatory Devices Average Price by Manufacturers (2018-2023)
2.4 Global Non-Invasive Neuromodulatory Devices Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Neuromodulatory Devices, Product Type & Application
2.7 Non-Invasive Neuromodulatory Devices Market Competitive Situation and Trends
2.7.1 Non-Invasive Neuromodulatory Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Invasive Neuromodulatory Devices Players Market Share by Revenue
2.7.3 Global Non-Invasive Neuromodulatory Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Invasive Neuromodulatory Devices Retrospective Market Scenario by Region
3.1 Global Non-Invasive Neuromodulatory Devices Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Invasive Neuromodulatory Devices Global Non-Invasive Neuromodulatory Devices Sales by Region: 2018-2029
3.2.1 Global Non-Invasive Neuromodulatory Devices Sales by Region: 2018-2023
3.2.2 Global Non-Invasive Neuromodulatory Devices Sales by Region: 2024-2029
3.3 Global Non-Invasive Neuromodulatory Devices Global Non-Invasive Neuromodulatory Devices Revenue by Region: 2018-2029
3.3.1 Global Non-Invasive Neuromodulatory Devices Revenue by Region: 2018-2023
3.3.2 Global Non-Invasive Neuromodulatory Devices Revenue by Region: 2024-2029
3.4 North America Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.4.1 North America Non-Invasive Neuromodulatory Devices Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Invasive Neuromodulatory Devices Sales by Country (2018-2029)
3.4.3 North America Non-Invasive Neuromodulatory Devices Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Neuromodulatory Devices Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Invasive Neuromodulatory Devices Sales by Country (2018-2029)
3.5.3 Europe Non-Invasive Neuromodulatory Devices Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Invasive Neuromodulatory Devices Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Invasive Neuromodulatory Devices Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Invasive Neuromodulatory Devices Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Neuromodulatory Devices Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Invasive Neuromodulatory Devices Sales by Country (2018-2029)
3.7.3 Latin America Non-Invasive Neuromodulatory Devices Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-Invasive Neuromodulatory Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Neuromodulatory Devices Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Invasive Neuromodulatory Devices Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Invasive Neuromodulatory Devices Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Neuromodulatory Devices Sales by Type (2018-2029)
4.1.1 Global Non-Invasive Neuromodulatory Devices Sales by Type (2018-2023)
4.1.2 Global Non-Invasive Neuromodulatory Devices Sales by Type (2024-2029)
4.1.3 Global Non-Invasive Neuromodulatory Devices Sales Market Share by Type (2018-2029)
4.2 Global Non-Invasive Neuromodulatory Devices Revenue by Type (2018-2029)
4.2.1 Global Non-Invasive Neuromodulatory Devices Revenue by Type (2018-2023)
4.2.2 Global Non-Invasive Neuromodulatory Devices Revenue by Type (2024-2029)
4.2.3 Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Type (2018-2029)
4.3 Global Non-Invasive Neuromodulatory Devices Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-Invasive Neuromodulatory Devices Sales by Application (2018-2029)
5.1.1 Global Non-Invasive Neuromodulatory Devices Sales by Application (2018-2023)
5.1.2 Global Non-Invasive Neuromodulatory Devices Sales by Application (2024-2029)
5.1.3 Global Non-Invasive Neuromodulatory Devices Sales Market Share by Application (2018-2029)
5.2 Global Non-Invasive Neuromodulatory Devices Revenue by Application (2018-2029)
5.2.1 Global Non-Invasive Neuromodulatory Devices Revenue by Application (2018-2023)
5.2.2 Global Non-Invasive Neuromodulatory Devices Revenue by Application (2024-2029)
5.2.3 Global Non-Invasive Neuromodulatory Devices Revenue Market Share by Application (2018-2029)
5.3 Global Non-Invasive Neuromodulatory Devices Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Neuroelectrics
6.1.1 Neuroelectrics Corporation Information
6.1.2 Neuroelectrics Description and Business Overview
6.1.3 Neuroelectrics Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Neuroelectrics Non-Invasive Neuromodulatory Devices Product Portfolio
6.1.5 Neuroelectrics Recent Developments/Updates
6.2 Aneuvo
6.2.1 Aneuvo Corporation Information
6.2.2 Aneuvo Description and Business Overview
6.2.3 Aneuvo Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aneuvo Non-Invasive Neuromodulatory Devices Product Portfolio
6.2.5 Aneuvo Recent Developments/Updates
6.3 Soterix Medical
6.3.1 Soterix Medical Corporation Information
6.3.2 Soterix Medical Description and Business Overview
6.3.3 Soterix Medical Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Soterix Medical Non-Invasive Neuromodulatory Devices Product Portfolio
6.3.5 Soterix Medical Recent Developments/Updates
6.4 Magstim
6.4.1 Magstim Corporation Information
6.4.2 Magstim Description and Business Overview
6.4.3 Magstim Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Magstim Non-Invasive Neuromodulatory Devices Product Portfolio
6.4.5 Magstim Recent Developments/Updates
6.5 BrainsWay
6.5.1 BrainsWay Corporation Information
6.5.2 BrainsWay Description and Business Overview
6.5.3 BrainsWay Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BrainsWay Non-Invasive Neuromodulatory Devices Product Portfolio
6.5.5 BrainsWay Recent Developments/Updates
6.6 ElectroCore Medical
6.6.1 ElectroCore Medical Corporation Information
6.6.2 ElectroCore Medical Description and Business Overview
6.6.3 ElectroCore Medical Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 ElectroCore Medical Non-Invasive Neuromodulatory Devices Product Portfolio
6.6.5 ElectroCore Medical Recent Developments/Updates
6.7 NeuroCare Group
6.6.1 NeuroCare Group Corporation Information
6.6.2 NeuroCare Group Description and Business Overview
6.6.3 NeuroCare Group Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NeuroCare Group Non-Invasive Neuromodulatory Devices Product Portfolio
6.7.5 NeuroCare Group Recent Developments/Updates
6.8 Koninklijke Philips
6.8.1 Koninklijke Philips Corporation Information
6.8.2 Koninklijke Philips Description and Business Overview
6.8.3 Koninklijke Philips Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Koninklijke Philips Non-Invasive Neuromodulatory Devices Product Portfolio
6.8.5 Koninklijke Philips Recent Developments/Updates
6.9 NESA World
6.9.1 NESA World Corporation Information
6.9.2 NESA World Description and Business Overview
6.9.3 NESA World Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 NESA World Non-Invasive Neuromodulatory Devices Product Portfolio
6.9.5 NESA World Recent Developments/Updates
6.10 DEYMED Diagnostic
6.10.1 DEYMED Diagnostic Corporation Information
6.10.2 DEYMED Diagnostic Description and Business Overview
6.10.3 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 DEYMED Diagnostic Non-Invasive Neuromodulatory Devices Product Portfolio
6.10.5 DEYMED Diagnostic Recent Developments/Updates
6.11 electroCore
6.11.1 electroCore Corporation Information
6.11.2 electroCore Non-Invasive Neuromodulatory Devices Description and Business Overview
6.11.3 electroCore Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.11.4 electroCore Non-Invasive Neuromodulatory Devices Product Portfolio
6.11.5 electroCore Recent Developments/Updates
6.12 Medistar
6.12.1 Medistar Corporation Information
6.12.2 Medistar Non-Invasive Neuromodulatory Devices Description and Business Overview
6.12.3 Medistar Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Medistar Non-Invasive Neuromodulatory Devices Product Portfolio
6.12.5 Medistar Recent Developments/Updates
6.13 Vagustim
6.13.1 Vagustim Corporation Information
6.13.2 Vagustim Non-Invasive Neuromodulatory Devices Description and Business Overview
6.13.3 Vagustim Non-Invasive Neuromodulatory Devices Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Vagustim Non-Invasive Neuromodulatory Devices Product Portfolio
6.13.5 Vagustim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Neuromodulatory Devices Industry Chain Analysis
7.2 Non-Invasive Neuromodulatory Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Neuromodulatory Devices Production Mode & Process
7.4 Non-Invasive Neuromodulatory Devices Sales and Marketing
7.4.1 Non-Invasive Neuromodulatory Devices Sales Channels
7.4.2 Non-Invasive Neuromodulatory Devices Distributors
7.5 Non-Invasive Neuromodulatory Devices Customers
8 Non-Invasive Neuromodulatory Devices Market Dynamics
8.1 Non-Invasive Neuromodulatory Devices Industry Trends
8.2 Non-Invasive Neuromodulatory Devices Market Drivers
8.3 Non-Invasive Neuromodulatory Devices Market Challenges
8.4 Non-Invasive Neuromodulatory Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
